Form 4: PetMed Express Director Awarded Restricted Stock
Insider Transaction Report
PetMed Express director Gian Fulgoni received a restricted stock award of 33,846 common shares, vesting in October 2026.
Summary
- Gian Fulgoni, a Director of PetMed Express Inc. (PETS), was granted 33,846 shares of common stock.
- The transaction occurred on October 30, 2025, and the shares were acquired at a price of $0, indicating a grant.
- This award is a restricted stock grant made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan.
- The granted shares will vest in full on October 30, 2026, contingent upon Mr. Fulgoni's continued service on the Board of Directors.
- Following this transaction, Mr. Fulgoni beneficially owns a total of 158,356 shares of common stock directly.
Sentiment
Score: 6
Explanation: The filing indicates a routine compensation event for a director, which is generally viewed as a neutral to slightly positive signal due to the alignment of interests between management and shareholders.
Positives
- The restricted stock award aligns the director's interests with those of shareholders, as the value of the award is tied to the company's stock performance.
- The vesting schedule encourages the director's continued service and long-term commitment to the company.
Future Outlook
The restricted stock award is set to vest on October 30, 2026, contingent on the director's continued service, indicating a future milestone for this compensation.
Industry Context
Restricted stock awards are a common form of executive and director compensation across various industries, designed to incentivize long-term performance and retention by linking compensation to company stock value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The restricted stock award was made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan, indicating the company's active use of its approved equity compensation framework. | 10/30/2025 | Reinforces the company's established compensation policies and practices for directors, promoting long-term commitment. |
Stakeholder Impact
- Shareholders: The award aligns the director's financial interests with shareholder value creation, potentially leading to more focused long-term decision-making.
- Employees: While not directly impacting employees, the use of an incentive plan can signal a broader commitment to performance-based compensation within the company.
Next Steps
- Continued service of Gian Fulgoni on the Board of Directors until the vesting date of October 30, 2026.
Key Dates
| Date | Description |
|---|---|
| 10/30/2025 | Date of transaction where 33,846 shares of common stock were acquired by Gian Fulgoni. |
| 11/03/2025 | Date the Form 4 was signed by Gian Fulgoni. |
| 10/30/2026 | Vesting date for all granted restricted stock shares, subject to continued service. |
Keywords
PETS, PetMed Express, Form 4, Insider Transaction, Restricted Stock Award, Director Compensation, Equity Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.